Semaglutide 10mg

Description

Semaglutide 10 mg is a research grade synthetic peptide supplied in lyophilized form for use in controlled laboratory environments. It is classified as a glucagon like peptide 1 receptor agonist and is widely studied in metabolic signaling research.

Researchers use Semaglutide to investigate incretin pathways, glucose regulation, appetite related neurocircuitry, gastric motility signaling, pancreatic beta cell activity, and broader mechanisms involved in energy balance.

Semaglutide is a modified analog of naturally occurring GLP 1. Its structure includes targeted amino acid substitutions and a fatty acid side chain designed to improve stability and support prolonged receptor interaction through noncovalent albumin association in experimental systems.

In cell based and preclinical models, Semaglutide has been studied for its effects on GLP 1 receptor activation, cyclic adenosine monophosphate production, insulinotropic signaling, beta cell response pathways, hypothalamic feeding circuits, delayed gastric emptying mechanisms, and adipose related metabolic regulation.

The 10 mg presentation is suitable for preliminary investigations, receptor activation studies, concentration response testing, metabolic signaling assays, pancreatic islet research, and comparative studies involving other incretin based compounds.

Each PEPTEX Labs production lot is supplied as a research grade lyophilized peptide with supporting analytical documentation. Testing may include reverse phase HPLC purity analysis, mass spectrometry identity verification, net content testing, and endotoxin analysis, depending on the individual batch.

This product is supplied exclusively for qualified laboratory research. It is not intended for human or veterinary use, diagnostic procedures, clinical administration, or therapeutic application. Laboratory personnel should follow appropriate handling, storage, and safety procedures.